By expenditures
| Name | Title | Type |
|---|---|---|
| Linda Scholting | Chief Financial Officer | Auditee |
| Julie Heyen | CONTROLLER | Auditee |
| Rebekah Martin | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 375536 | 2025 | 2025-12-17 | BAKER TILLY US LLP | $12.75M |
| 331806 | 2024 | 2024-12-11 | Baker Tilly US LLP | $12.87M |
| 293420 | 2023 | 2024-03-04 | Baker Tilly US LLP | $12.49M |
| 39674 | 2022 | 2023-02-27 | Baker Tilly US LLP | $18.48M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 375536 | 2025 | 2025-12-17 | 1165224 | 2025-003 | Material Weakness | Yes | N |
| 375536 | 2025 | 2025-12-17 | 1165223 | 2025-002 | Material Weakness | Yes | N |
| 375536 | 2025 | 2025-12-17 | 1165222 | 2025-001 | Material Weakness | Yes | N |
| 331806 | 2024 | 2024-12-11 | 1090273 | 2024-001 | Significant Deficiency | - | N |
| 331806 | 2024 | 2024-12-11 | 513831 | 2024-001 | Significant Deficiency | - | N |
| 293420 | 2023 | 2024-03-04 | 948572 | 2023-002 | - | - | N |
| 293420 | 2023 | 2024-03-04 | 948571 | 2023-001 | - | - | N |
| 293420 | 2023 | 2024-03-04 | 372130 | 2023-002 | - | - | N |
| 293420 | 2023 | 2024-03-04 | 372129 | 2023-001 | - | - | N |
| 39674 | 2022 | 2023-02-27 | 622196 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 622195 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 622194 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 622193 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 622192 | 2022-003 | Significant Deficiency | - | CLN |
| 39674 | 2022 | 2023-02-27 | 622191 | 2022-002 | Significant Deficiency | - | N |
| 39674 | 2022 | 2023-02-27 | 622190 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 622189 | 2022-003 | Significant Deficiency | - | CLN |
| 39674 | 2022 | 2023-02-27 | 622188 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 622187 | 2022-003 | Significant Deficiency | - | CLN |
| 39674 | 2022 | 2023-02-27 | 622186 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 622185 | 2022-003 | Significant Deficiency | - | CLN |
| 39674 | 2022 | 2023-02-27 | 622184 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 622183 | 2022-003 | Significant Deficiency | - | CLN |
| 39674 | 2022 | 2023-02-27 | 622182 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 622181 | 2022-003 | Significant Deficiency | - | CLN |
| 39674 | 2022 | 2023-02-27 | 45754 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 45753 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 45752 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 45751 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 45750 | 2022-003 | Significant Deficiency | - | CLN |
| 39674 | 2022 | 2023-02-27 | 45749 | 2022-002 | Significant Deficiency | - | N |
| 39674 | 2022 | 2023-02-27 | 45748 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 45747 | 2022-003 | Significant Deficiency | - | CLN |
| 39674 | 2022 | 2023-02-27 | 45746 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 45745 | 2022-003 | Significant Deficiency | - | CLN |
| 39674 | 2022 | 2023-02-27 | 45744 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 45743 | 2022-003 | Significant Deficiency | - | CLN |
| 39674 | 2022 | 2023-02-27 | 45742 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 45741 | 2022-003 | Significant Deficiency | - | CLN |
| 39674 | 2022 | 2023-02-27 | 45740 | 2022-004 | Significant Deficiency | - | L |
| 39674 | 2022 | 2023-02-27 | 45739 | 2022-003 | Significant Deficiency | - | CLN |